Skip to main content
. 2021 Jul;10(7):3155–3172. doi: 10.21037/tlcr-21-356

Table 2. The correlations of the serum miR-375-3p level with SCLC clinical features in cohort 3.

Clinical features Group Low miR-375-3p expression High miR-375-3p expression P value
Sex Female 6 8 0.5906
Male 28 27
Age <60 14 14 0.9207
≥60 20 21
T T1-T2 19 9 0.0107*
T3-T4 15 26
N N0-N1 9 1 0.0053**
N2-N3 25 34
M M0 23 17 0.1085
M1 11 18
Stage I-II 5 0 0.0185*
III-IV 29 35

SCLC, small cell lung cancer; T, tumor; N, node; M, metastasis. *, P<0.05; **, P<0.01.